C-Jun-mediated anticancer mechanisms of tylophorine

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1304-1314

  Yang, Cheng Wei ^a,b   Lee, Yue Zhi ^a   Hsu, Hsing Yu ^a   Wu, Chia Mao ^a   Chang, Hwan You ^b   Chao, Yu Sheng ^a   Lee, Shiow Ju ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; CYCLIN A2; ELONGATION FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C DELTA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TYLOPHORINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME STABILITY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSLATION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 1; ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CELL LINE, TUMOR; CYCLIN A2; DOWN-REGULATION; ELONGATION FACTOR 2 KINASE; EUKARYOTIC INITIATION FACTORS; G1 PHASE CELL CYCLE CHECKPOINTS; HEP G2 CELLS; HUMANS; INDOLIZINES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PHENANTHRENES; PHENANTHROLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-DELTA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TYLOPHORA;

EID: 84878970288     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt039     Document Type: Article

References (33)

1. Chemler,S.R. (2009) Phenanthroindolizidines and phenanthroquinolizidines: promising alkaloids for anti-cancer therapy. Curr. Bioact. Compd., 5, 2-19.
2. Yan,J. et al. (2006) Induction of G1 arrest and differentiation in MDA-MB-231 breast cancer cell by boehmeriasin A, a novel compound from plant. Int. J. Gynecol. Cancer, 16, 165-170.
3. Shiah,H.S. et al. (2006) Inhibition of cell growth and nuclear factorkappaB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503. Mol. Cancer Ther., 5, 2484-2493.
4. Gao,W. et al. (2004) Novel mode of action of tylophorine analogs as antitumor compounds. Cancer Res., 64, 678-688.
5. Lee,S.K. et al. (2003) Cytotoxic activity and G2/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum. Planta Med., 69, 21-25.
6. Wu,C.M. et al. (2009) Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression. Biochem. Biophys. Res. Commun., 386, 140-145.
7. Lee,Y.Z. et al. (2012) Synthesis and biological evaluation of tylophorinederived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity. J. Med. Chem., 55, 10363-10377.
8. Verde,P. et al. (2007) Deciphering AP-1 function in tumorigenesis: fraternizing on target promoters. Cell Cycle, 6, 2633-2639.
9. Turpaev,K.T. (2006) Role of transcription factor AP-1 in integration of cellular signalling systems. Mol. Biol. (Mosk.), 40, 945-961.
10. Weiss,C. et al. (2008) TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene, 27, 2198-2207.
11. Cho,J.W. et al. (2008) AP-1 transcription factor decoy reduces the TGFbeta1- induced cell growth in scleroderma fibroblasts through inhibition of cyclin E. Oncol. Rep., 19, 737-741.
12. Raivich,G. (2008) c-Jun expression, activation and function in neural cell death, inflammation and repair. J. Neurochem., 107, 898-906.
13. Sehgal,A. et al. (2000) The chicken c-Jun 5' untranslated region directs translation by internal initiation. Oncogene, 19, 2836-2845.
14. Polak,P. et al. (2006) The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene, 25, 665-676.
15. Musti,A.M. et al. (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science, 275, 400-402.
16. Fuchs,S.Y. et al. (1996) Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene, 13, 1531-1535.
17. Paul,A. et al. (1997) Stress-activated protein kinases: activation, regulation and function. Cell. Signal., 9, 403-410.
18. Greene,M.W. et al. (2010) TNFalpha activation of PKCdelta, mediated by NFkappaB and ER stress, cross-talks with the insulin signaling cascade. Cell. Signal., 22, 274-284.
19. Holland,E.C. et al. (2004) Signaling control of mRNA translation in cancer pathogenesis. Oncogene, 23, 3138-3144.
20. Yang,C.W. et al. (2006) Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids. Mol. Pharmacol., 69, 749-758.
21. Henglein,B. et al. (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. U.S.A., 91, 5490-5494.
22. Katabami,M. et al. (2005) Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in RAT1a cells. J. Biol. Chem., 280, 16728-16738.
23. Treier,M. et al. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell, 78, 787-798.
24. Musti,A.M. et al. (1996) Differential regulation of c-Jun and JunD by ubiquitin- dependent protein degradation. Biol. Chem., 377, 619-624.
25. Wancket,L.M. et al. (2012) Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease. Life Sci., 90, 237-248.
26. Soltoff,S.P. (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol. Sci., 28, 453-458.
27. Hattori,K. et al. (1988) Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc. Natl. Acad. Sci. U.S.A., 85, 9148-9152.
28. Groot,M. et al. (2000) Nerve growth factor- and epidermal growth factorregulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. Eur. J. Cell Biol., 79, 924-935.
29. Herr,I. et al. (1994) Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis, 15, 1105-1113.
30. Huang,M.T. et al. (1972) Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis. Mol. Pharmacol., 8, 538-550.
31. Imler,J.L. et al. (1989) AP1, a composite transcription factor implicated in abnormal growth control. Prog. Growth Factor Res., 1, 69-77.
32. Blattner,C. et al. (2000) UV-Induced stabilization of c-fos and other shortlived mRNAs. Mol. Cell. Biol., 20, 3616-3625.
33. Liu,J. et al. (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res., 15, 36-42.